BR112017024786A2 - virus oncolíticos recombinantes e usos dos mesmos - Google Patents
virus oncolíticos recombinantes e usos dos mesmosInfo
- Publication number
- BR112017024786A2 BR112017024786A2 BR112017024786A BR112017024786A BR112017024786A2 BR 112017024786 A2 BR112017024786 A2 BR 112017024786A2 BR 112017024786 A BR112017024786 A BR 112017024786A BR 112017024786 A BR112017024786 A BR 112017024786A BR 112017024786 A2 BR112017024786 A2 BR 112017024786A2
- Authority
- BR
- Brazil
- Prior art keywords
- oncolytic viruses
- recombinant oncolytic
- polypeptide
- relates
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
- C12N2760/20232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
- C12N2760/20241—Use of virus, viral particle or viral elements as a vector
- C12N2760/20243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
a presente invenção se refere a vírus oncolíticos recombinantes. mais especificamente, a presente invenção se refere a vírus oncolíticos recombinantes que expressam um polipeptídeo que atrai células b heterólogas ou um polipeptídeo que atrai células t.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562163918P | 2015-05-19 | 2015-05-19 | |
PCT/IB2016/052922 WO2016185414A1 (en) | 2015-05-19 | 2016-05-19 | Recombinant oncolytic viruses and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112017024786A2 true BR112017024786A2 (pt) | 2018-12-04 |
Family
ID=57319552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112017024786A BR112017024786A2 (pt) | 2015-05-19 | 2016-05-19 | virus oncolíticos recombinantes e usos dos mesmos |
Country Status (9)
Country | Link |
---|---|
US (1) | US20180133270A1 (pt) |
EP (1) | EP3298132A4 (pt) |
JP (1) | JP2018519805A (pt) |
CN (1) | CN108138149A (pt) |
AU (1) | AU2016263147A1 (pt) |
BR (1) | BR112017024786A2 (pt) |
CA (1) | CA3023817A1 (pt) |
HK (1) | HK1255099A1 (pt) |
WO (1) | WO2016185414A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107586759B (zh) * | 2017-11-03 | 2021-03-30 | 广西医科大学 | 一种重组新城疫病毒的构建方法及应用 |
CN117957323A (zh) * | 2021-08-13 | 2024-04-30 | 深圳市华药康明生物药业有限责任公司 | 经修饰的痘苗病毒及其应用 |
CN113980915B (zh) * | 2021-11-04 | 2023-07-07 | 江苏省人民医院(南京医科大学第一附属医院) | 一种新型的表达cxcl10的复制型溶瘤腺病毒和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5824299A (en) * | 1995-06-22 | 1998-10-20 | President & Fellows Of Harvard College | Modulation of endothelial cell proliferation with IP-10 |
WO2003005964A2 (en) * | 2001-07-11 | 2003-01-23 | University Of Miami | Recombinant vsv for the treatment of tumor cells |
US20080227704A1 (en) * | 2006-12-21 | 2008-09-18 | Kamens Joanne S | CXCL13 binding proteins |
JP6415977B2 (ja) * | 2011-04-15 | 2018-10-31 | ジェネラックス・コーポレイションGenelux Corporation | 弱毒化ワクシニアウイルスのクローン株およびその使用方法 |
KR20160002971A (ko) * | 2013-04-18 | 2016-01-08 | 틸트 바이오세러퓨틱스 오이 | 향상된 입양 세포 치료 |
-
2016
- 2016-05-19 AU AU2016263147A patent/AU2016263147A1/en not_active Abandoned
- 2016-05-19 US US15/574,685 patent/US20180133270A1/en not_active Abandoned
- 2016-05-19 CA CA3023817A patent/CA3023817A1/en not_active Abandoned
- 2016-05-19 JP JP2017560592A patent/JP2018519805A/ja not_active Abandoned
- 2016-05-19 EP EP16795996.4A patent/EP3298132A4/en not_active Withdrawn
- 2016-05-19 WO PCT/IB2016/052922 patent/WO2016185414A1/en active Application Filing
- 2016-05-19 CN CN201680041145.3A patent/CN108138149A/zh active Pending
- 2016-05-19 BR BR112017024786A patent/BR112017024786A2/pt not_active Application Discontinuation
-
2018
- 2018-11-08 HK HK18114252.4A patent/HK1255099A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HK1255099A1 (zh) | 2019-08-02 |
WO2016185414A1 (en) | 2016-11-24 |
EP3298132A4 (en) | 2019-02-13 |
CN108138149A (zh) | 2018-06-08 |
CA3023817A1 (en) | 2016-11-24 |
EP3298132A1 (en) | 2018-03-28 |
JP2018519805A (ja) | 2018-07-26 |
AU2016263147A1 (en) | 2018-01-18 |
US20180133270A1 (en) | 2018-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3400293T3 (da) | Modificeret onkolytisk virus | |
IL263373A (en) | Genetically modified vaccinia virus, preparations containing it and its uses | |
BR112019001737A2 (pt) | expressão de pten-long com vírus oncolíticos | |
EA201791460A1 (ru) | N4-гидроксицитидин и связанные с ним производные и варианты противовирусного применения | |
BR112017005381A2 (pt) | composições que compreendem células recombinantes de bacillus e um inseticida. | |
CL2018000432A1 (es) | Vacunas terapéuticas contra el hpv18 | |
NZ729012A (en) | Recombinant modified vaccinia virus ankara (mva) filovirus vaccine | |
BR112016022841A2 (pt) | cadeia j modificada | |
EA201690403A1 (ru) | Композиции и способы для модулирования рнк | |
BR112017005507A2 (pt) | composições que compreendem células recombinantes de bacillus e um fungicida. | |
ECSP15011603A (es) | Subunidades de vacunas de inmersión para peces | |
BR112017005504A2 (pt) | composições que compreendem células recombinantes de bacillus e um inseticida. | |
BR112017005379A2 (pt) | composições que compreendem células recombinantes de bacillus e um fungicida. | |
EA201691945A1 (ru) | Антитела к гемагглютинину вируса гриппа типа b и способы их применения | |
EA201692025A1 (ru) | Доставка белков, осуществляемая на основе бактерий | |
DK3768305T3 (da) | Modificerede, onkolytiske adenovira | |
CU24580B1 (es) | Vectores atenuados de influenza para la prevención y/o tratamiento de enfermedades infecciosas y para el tratamiento de enfermedades oncológicas | |
MY183072A (en) | Methods and compositions for inducing protective immunity against filovirus infection | |
EA201890322A1 (ru) | Новый вид тобамовируса | |
EA201401020A1 (ru) | Растения томата с фенотипом intense и устойчивостью к tylcv | |
AR101814A1 (es) | Partícula de tipo virus flavivirus | |
WO2014152946A3 (en) | Polypeptides for treating and/or limiting influenza infection | |
BR112017024786A2 (pt) | virus oncolíticos recombinantes e usos dos mesmos | |
KR20180084995A (ko) | Fmdv 및 e2 융합 단백질 및 이의 용도 | |
MX2015010763A (es) | Proteinas h5 del virus de la gripe h5n1 para uso como un medicamento. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |